Regeneron Pharmaceuticals 8-K Report: Key Updates & Insights (October 2025)

Based on the provided section of a financial report, here are the key insights:

1. Entity Information:

• Company Name: Regeneron Pharmaceuticals, Inc.
• CIK: 0000872589
• SEC File Number: 000-19034
• EIN: 13-3444607
• Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
• Phone Number: 914-847-7000

2. Filing Type:

• This is an 8-K filing, which typically reports significant events that shareholders should know about.

3. Date of Filing:

• Filing Date: October 6, 2025

4. Stock Information:

• Security Type: Common Stock
• Par Value: $0.001 per share
• Ticker Symbol: REGN
• Exchange: NASDAQ

5. Measurement Units:

• Financial figures are presented in USD (United States Dollar).
• Shares are also a unit of measurement mentioned.

6. Context Information:

• The context of the report is as of October 6, 2025, which indicates that the data provided is as of this specific date.

Insights:

• The 8-K filing indicates that Regeneron Pharmaceuticals is communicating important information to its investors or the market as of the specified date.
• The company's common stock is listed on NASDAQ, which is relevant for potential investors or stakeholders looking for trading information.
• The low par value of the common stock suggests a typical structure for shares in a publicly traded company, allowing for flexibility in share issuance and potential future stock splits.

This information is critical for investors, analysts, and stakeholders monitoring Regeneron's performance and market activities.